10:11 AM EST - Satellos Bioscience Inc. : Announced today the formation of a Clinical Advisory Board comprised of distinguished clinical research leaders and experts in drug development in genetic muscle disorders, including Duchenne muscular dystrophy. Satellos Bioscience Inc.
shares T.MSCL are trading up $0.02 at $0.50.
